au.\*:("OGISHIMA, Tatsuya")
Results 1 to 7 of 7
Selection :
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancerENOKIDA, Hideki; SHIINA, Hiroaki; KANE, Christopher J et al.International journal of cancer. 2005, Vol 116, Num 2, pp 174-181, issn 0020-7136, 8 p.Article
Increased Heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancerOGISHIMA, Tatsuya; SHIINA, Hiroaki; TERASHIMA, Masaharu et al.Clinical cancer research. 2005, Vol 11, Num 3, pp 1028-1036, issn 1078-0432, 9 p.Article
Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancerOGISHIMA, Tatsuya; SHIINA, Hiroaki; FUJIME, Makoto et al.Oncogene (Basingstoke). 2005, Vol 24, Num 45, pp 6765-6772, issn 0950-9232, 8 p.Article
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate CarcinomaENOKIDA, Hideki; SHIINA, Hiroaki; IGAWA, Mikio et al.Cancer. 2006, Vol 106, Num 1, pp 79-86, issn 0008-543X, 8 p.Article
Androgen, estrogen, and progesterone receptor gene regulation during diabetic erectile dysfunction and insulin treatmentSHIRAI, Masato; YAMANAKA, Masaki; SHIINA, Hiroaki et al.Urology (Ridgewood, NJ). 2004, Vol 64, Num 6, pp 1244-1249, issn 0090-4295, 6 p.Article
Epigenetic inactivation of wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathwayURAKAMI, Shinji; SHIINA, Hiroaki; KIKUNO, Nobuyuki et al.Clinical cancer research. 2006, Vol 12, Num 2, pp 383-391, issn 1078-0432, 9 p.Article
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancerENOKIDA, Hideki; SHIINA, Hiroaki; VERMA, Mukesh et al.Cancer research (Baltimore). 2004, Vol 64, Num 17, pp 5956-5962, issn 0008-5472, 7 p.Article